CTXR vs GRMN · rev $7.1M vs P/E 28, rev $7.25B
Citius Pharmaceuticals Inc (CTXR) versus Garmin Ltd (GRMN) — a side-by-side from cached financials, not a winner call.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
CTXR currently screens at market cap $13.4M. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Not investment advice. Open the CTXR and GRMN stock pages for the full models.
Not investment advice.